To assess the role of POSTN in tumorigenicity of pancreatic cancer cells in vivo, we established a subcutaneous cell-derived xenograft (CDX) model by co-injecting BxPC-3 cells with CAF-NC or CAF-POSTN into BALB/c-Nude mice. Here, POSTN is linked to pancreatic neoplasm.